Alpha Cognition Inc (TSE:ACOG) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Alpha Cognition Inc., a biopharmaceutical company targeting neurodegenerative disorders, has announced its participation in the Emerging Growth Conference on April 3, 2024. The event will feature interactive sessions with the CEO and COO, who will discuss the company’s lead Alzheimer’s treatment, ALPHA-1062. The presentation aims to connect with investors and provide updates, with the opportunity for live Q&A.
For further insights into TSE:ACOG stock, check out TipRanks’ Stock Analysis page.